Serum biomarkers of brain cancer
|Dr Andrew Morokoffemail@example.com||9035 8586|
This project aims to discover new biomarkers in the circulation that can predict the behaviour of brain cancer. Currently brain tumours are monitored using contrast-enhanced MRI, however this imaging modality has a number of limitations. For instance, contrast enhancement can be switched off after treatment with anti-angiogenic drugs. Furthermore, MRI is expensive and inconvenient for patients. We aim to find biomarkers using a simple blood test - otherwise known as a 'liquid biopsy'. The advantages of this are rapid, frequent minimally invasive assessment, even at a distance for patients who don't live in major city centres. Various biological parameters have been envalutated including circulating endothelial cells, circulating DNA and protein growth factors. Our current strategy utilises high throughput Nanostring sequencing technology to screen micro-RNA. We integrate our laboratory with large clinical databases of brain tumour patients linked with molecular and radiological data to determine statistical correlations with outcomes.
Circulating MicroRNA as Biomarkers - Interview (watch video here)
Dr Andrew Morokoff - Neurosurgeon and Senior Lecturer
Professor Andrew Kaye, Neurosurgeon
A/Prof Kate Drummond - Neurosurgeon and Researcher
Dr Rod Luwor - Senior Scientist
Dr Stanley Stylli - Senior Scientist
Lucy Paradiso - Research Assistant
Professor Tali Siegal- Neuro-Oncologist (Rabin Medical Centre, Tel Aviv, Israel)
Dr Iris Lavon (Hadassah Medical Centre, Israel)
Dr Chenkai Ma - PhD student
Dr Rachel Koldej -Senior Scientist
Dr Andrew Webb, WEHI
Dr Jason Li - Peter MacCallum Cancer Institute
Professor Izhak Haviv (Bar-Ilan University, Safed, Israel)
Igal Sherman (Hebrew University, Jerusalem, Israel)
Cure Brain Cancer Foundation
Royal Melbourne Hospital Neuroscience Foundation
Royal Melbourne Hospital Watt-Geyer Neuro-Oncology Research Fellowship
Beanies fo Brain Cancer Fund
1.Siegal, T., Charbit, H., Paldor, I., Zelikovitch, B., Canello, T., Benis, A., Wong, M. L., Morokoff, A. P., Kaye, A. H., and Lavon, I. (2016). Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab. J Neurosurg, 1-8.
2.Areeb, Z., Stylli, S. S., Koldej, R., Ritchie, D. S., Siegal, T., Morokoff, A. P., Kaye, A. H., and Luwor, R. B. (2015). MicroRNA as potential biomarkers in Glioblastoma. J Neurooncol 125, 237-248.
3.Bennett, I. E., Guo, H., Kountouri, N., D'Abaco G, M., Hovens, C. M., Moffat, B. A., Desmond, P., Drummond, K., Kaye, A. H., and Morokoff, A. P. (2015). Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiforme. J Clin Neurosci 22, 1802-1808.